UK wants results of breast implant review this week

Key points
- Britain expects the results of a review of breast implant safety to come this week following a global health scare focused on products from a now defunct French company, Health Secretary Andrew Lansley said on Wednesday.
- The British government is sticking to its advice that routine removal of implants from Poly Implant Prothese (PIP) is not required, in contrast to the guidance from the French government.
- Lansley said he was concerned about the quality of data supplied by private clinics and healthcare providers but that experts should be able to give definitive advice by the end of the week to an estimated 40,000 British women fitted with the implants.
- "On the basis of the evidence and the data that they have seen so far, their advice continues to be that there is no case for the routine removal of these implants because there isn't a safety concern that would justify the risk of a surgical operation," he told BBC radio.
Britain expects the results of a review of breast implant safety to come this week following a global health scare focused on products from a now defunct French company, Health Secretary Andrew Lansley said on Wednesday.
The British government is sticking to its advice that routine removal of implants from Poly Implant Prothese (PIP) is not required, in contrast to the guidance from the French government.
Lansley said he was concerned about the quality of data supplied by private clinics and healthcare providers but that experts should be able to give definitive advice by the end of the week to an estimated 40,000 British women fitted with the implants.
"On the basis of the evidence and the data that they have seen so far, their advice continues to be that there is no case for the routine removal of these implants because there isn't a safety concern that would justify the risk of a surgical operation," he told BBC radio.
"There is no evidence of a link with cancer, the toxicity tests have demonstrated to the satisfaction of the regulator that the filler in this material is not toxic."
The French government has advised 30,000 French women who bought implants from PIP to have them removed because of concerns that they might rupture.
Once the third-biggest breast implant maker in the world, PIP went bankrupt in 2010 after an official investigation showed it was using cheaper, unapproved industrial-grade silicone in some of its products.
###
Reuters
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBreast cancer treatment offers better outcome to women with implants
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual…
2 December 2008
NewsBreast implants linked to suicide, but not cancer
A large Canadian study adds to evidence that women with breast implants do not face a higher risk of cancer or other major diseases, but they may have a higher-than-average rate of suicide. Among the more than 40,000…
19 August 2006
NewsNo cancer risk seen with breast implants
Cosmetic breast implants do not seem to increase the risk of cancer, according to the results of a population-based study with more than 15 years of follow-up. A slightly elevated risk of lung cancer was noted in…
20 April 2006
